Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women

During pregnancy, interpretation of results from coagulation parameters can be difficult as the physiological changes that occur may affect the biochemical parameters. The aim of this study was to describe the normal course of five coagulation parameters in healthy pregnancies, and to estimate the w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical chemistry and laboratory medicine Jg. 56; H. 8; S. 1297
Hauptverfasser: Kristoffersen, Ann Helen, Petersen, Per Hyltoft, Bjørge, Line, Røraas, Thomas, Sandberg, Sverre
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Germany 26.07.2018
Schlagworte:
ISSN:1437-4331, 1437-4331
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract During pregnancy, interpretation of results from coagulation parameters can be difficult as the physiological changes that occur may affect the biochemical parameters. The aim of this study was to describe the normal course of five coagulation parameters in healthy pregnancies, and to estimate the within-subject biological variation (CVI). Blood samples were obtained every 4th week during pregnancy and three samples after delivery in 20 healthy women and every 4th week during a 40-week period in 19 healthy non-pregnant women. Activated partial thromboplastin time (APTT), prothrombin time (PT), PT International Normalized Ratio (INR), fibrinogen, factor VIII clot (FVIII:C) and von Willebrand factor antigen (vWF:Ag) were analyzed. The physiological changes during pregnancy were compensated by transformation into multiples of the median (MoM) and it is natural logarithm (lnMoM) in order to establish a kind of steady state, and CVI was calculated from the standard deviation. During pregnancy, APTT, PT and INR remained unchanged or decreased, depending upon the reagent used, while fibrinogen, FVIII:C and vWF:Ag increased gradually until delivery. The CVI in pregnancy were 2.2 and 3.0% for APTT, 2.3 and 2.6% for PT, 2.2 and 2.3% for INR, 7.2% for fibrinogen, 12.2% for FVIII:C and 11.3% for vWF:Ag, and corresponded with the CVI in non-pregnant women. Transformation of coagulation parameters in healthy pregnancies to MoM is a tool to establish a kind of steady state. Although there is a physiological change in these coagulation parameters during pregnancy, the CVI after lnMoM transformation was comparable with the CVI of non-pregnant women.
AbstractList During pregnancy, interpretation of results from coagulation parameters can be difficult as the physiological changes that occur may affect the biochemical parameters. The aim of this study was to describe the normal course of five coagulation parameters in healthy pregnancies, and to estimate the within-subject biological variation (CVI). Blood samples were obtained every 4th week during pregnancy and three samples after delivery in 20 healthy women and every 4th week during a 40-week period in 19 healthy non-pregnant women. Activated partial thromboplastin time (APTT), prothrombin time (PT), PT International Normalized Ratio (INR), fibrinogen, factor VIII clot (FVIII:C) and von Willebrand factor antigen (vWF:Ag) were analyzed. The physiological changes during pregnancy were compensated by transformation into multiples of the median (MoM) and it is natural logarithm (lnMoM) in order to establish a kind of steady state, and CVI was calculated from the standard deviation. During pregnancy, APTT, PT and INR remained unchanged or decreased, depending upon the reagent used, while fibrinogen, FVIII:C and vWF:Ag increased gradually until delivery. The CVI in pregnancy were 2.2 and 3.0% for APTT, 2.3 and 2.6% for PT, 2.2 and 2.3% for INR, 7.2% for fibrinogen, 12.2% for FVIII:C and 11.3% for vWF:Ag, and corresponded with the CVI in non-pregnant women. Transformation of coagulation parameters in healthy pregnancies to MoM is a tool to establish a kind of steady state. Although there is a physiological change in these coagulation parameters during pregnancy, the CVI after lnMoM transformation was comparable with the CVI of non-pregnant women.
During pregnancy, interpretation of results from coagulation parameters can be difficult as the physiological changes that occur may affect the biochemical parameters. The aim of this study was to describe the normal course of five coagulation parameters in healthy pregnancies, and to estimate the within-subject biological variation (CVI).BACKGROUNDDuring pregnancy, interpretation of results from coagulation parameters can be difficult as the physiological changes that occur may affect the biochemical parameters. The aim of this study was to describe the normal course of five coagulation parameters in healthy pregnancies, and to estimate the within-subject biological variation (CVI).Blood samples were obtained every 4th week during pregnancy and three samples after delivery in 20 healthy women and every 4th week during a 40-week period in 19 healthy non-pregnant women. Activated partial thromboplastin time (APTT), prothrombin time (PT), PT International Normalized Ratio (INR), fibrinogen, factor VIII clot (FVIII:C) and von Willebrand factor antigen (vWF:Ag) were analyzed. The physiological changes during pregnancy were compensated by transformation into multiples of the median (MoM) and it is natural logarithm (lnMoM) in order to establish a kind of steady state, and CVI was calculated from the standard deviation.METHODSBlood samples were obtained every 4th week during pregnancy and three samples after delivery in 20 healthy women and every 4th week during a 40-week period in 19 healthy non-pregnant women. Activated partial thromboplastin time (APTT), prothrombin time (PT), PT International Normalized Ratio (INR), fibrinogen, factor VIII clot (FVIII:C) and von Willebrand factor antigen (vWF:Ag) were analyzed. The physiological changes during pregnancy were compensated by transformation into multiples of the median (MoM) and it is natural logarithm (lnMoM) in order to establish a kind of steady state, and CVI was calculated from the standard deviation.During pregnancy, APTT, PT and INR remained unchanged or decreased, depending upon the reagent used, while fibrinogen, FVIII:C and vWF:Ag increased gradually until delivery. The CVI in pregnancy were 2.2 and 3.0% for APTT, 2.3 and 2.6% for PT, 2.2 and 2.3% for INR, 7.2% for fibrinogen, 12.2% for FVIII:C and 11.3% for vWF:Ag, and corresponded with the CVI in non-pregnant women.RESULTSDuring pregnancy, APTT, PT and INR remained unchanged or decreased, depending upon the reagent used, while fibrinogen, FVIII:C and vWF:Ag increased gradually until delivery. The CVI in pregnancy were 2.2 and 3.0% for APTT, 2.3 and 2.6% for PT, 2.2 and 2.3% for INR, 7.2% for fibrinogen, 12.2% for FVIII:C and 11.3% for vWF:Ag, and corresponded with the CVI in non-pregnant women.Transformation of coagulation parameters in healthy pregnancies to MoM is a tool to establish a kind of steady state. Although there is a physiological change in these coagulation parameters during pregnancy, the CVI after lnMoM transformation was comparable with the CVI of non-pregnant women.CONCLUSIONSTransformation of coagulation parameters in healthy pregnancies to MoM is a tool to establish a kind of steady state. Although there is a physiological change in these coagulation parameters during pregnancy, the CVI after lnMoM transformation was comparable with the CVI of non-pregnant women.
Author Bjørge, Line
Petersen, Per Hyltoft
Røraas, Thomas
Kristoffersen, Ann Helen
Sandberg, Sverre
Author_xml – sequence: 1
  givenname: Ann Helen
  surname: Kristoffersen
  fullname: Kristoffersen, Ann Helen
  organization: Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway
– sequence: 2
  givenname: Per Hyltoft
  surname: Petersen
  fullname: Petersen, Per Hyltoft
  organization: Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway
– sequence: 3
  givenname: Line
  surname: Bjørge
  fullname: Bjørge, Line
  organization: Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway
– sequence: 4
  givenname: Thomas
  surname: Røraas
  fullname: Røraas, Thomas
  organization: Norwegian Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway
– sequence: 5
  givenname: Sverre
  surname: Sandberg
  fullname: Sandberg, Sverre
  organization: Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29648994$$D View this record in MEDLINE/PubMed
BookMark eNpNUMlOwzAUtFARXeDKEfnIgYCXJI6PqGKphMQF6LHyltaVYwfHKeJ7-FGCWhCnN29m3kjzpmDkgzcAnGN0jQtc3CjlmowgzDJMCDoCE5xTluWU4tE_PAbTrtsihIsiZydgTHiZV5znE_C1tGljfdb1cmtUgtIGF9ZWCQd3IlqRbPAw1FCoZHciGQ1bEZMd5LSJoZGhdaJL1sNkG3MF2xj2_B9TWxmtD2vjBzykhAjfFosFFF7D3ZC9tM4ZGX_WgzycttGsvfAJfoTG-FNwXAvXmbPDnIHX-7uX-WP29PywmN8-ZYoyljJOa641IhWrOGGkKonglCgsGc650ExTXpRk8GqtEC0rqqRGoqSVZIIXtSIzcLnPHVq896ZLq8Z2yjgnvAl9tyKIFBSTgvDBenGw9rIxetVG24j4ufp9LPkGl_R_ng
CitedBy_id crossref_primary_10_1016_j_cca_2020_06_030
crossref_primary_10_1177_10760296211070004
crossref_primary_10_1111_ijlh_14382
crossref_primary_10_1177_0004563219869732
crossref_primary_10_1177_10760296221151166
crossref_primary_10_1515_cclm_2022_1207
crossref_primary_10_1515_cclm_2022_1255
crossref_primary_10_1016_j_cca_2025_120141
crossref_primary_10_1016_j_cca_2024_117806
crossref_primary_10_1093_clinchem_hvab100
ContentType Journal Article
DBID NPM
7X8
DOI 10.1515/cclm-2017-1220
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1437-4331
ExternalDocumentID 29648994
Genre Journal Article
GroupedDBID ---
0R~
0~D
29B
354
36B
4.4
53G
5GY
5RE
AAAEU
AABBZ
AAFPC
AAGVJ
AAILP
AALGR
AAONY
AAOQK
AAOWA
AAPJK
AAQCX
AASQH
AAWFC
AAXCG
ABAOT
ABAQN
ABFKT
ABFQV
ABIQR
ABJNI
ABLJU
ABMIY
ABPLS
ABRDF
ABRQL
ABUVI
ABVMU
ABWLS
ABXMZ
ABYBW
ACDEB
ACEFL
ACGFS
ACIWK
ACMKP
ACPMA
ACPRK
ACXLN
ACZBO
ADDWE
ADEQT
ADGQD
ADGYE
ADOZN
AEDGQ
AEGVQ
AEICA
AEJTT
AEKEB
AENEX
AEQDQ
AERZL
AEXIE
AFBAA
AFBDD
AFBQV
AFCXV
AFGDO
AFGNR
AFQUK
AFRAH
AFYRI
AGBEV
AHOVO
AHVWV
AHXUK
AIERV
AIKXB
AIWOI
AJATJ
AJHHK
AKXKS
ALMA_UNASSIGNED_HOLDINGS
ALUKF
ALYBR
AMAVY
ASYPN
AZMOX
BAKPI
BBCWN
BCIFA
BWHEM
CGQUA
CS3
DU5
EBS
EJD
EMOBN
F5P
FSTRU
HZ~
IY9
KDIRW
N9A
NPM
O9-
OBC
OBS
OEB
OES
OHH
OVD
P2P
PQQKQ
QD8
RDG
SA.
SLJYH
TEORI
UK5
WTRAM
7X8
AARRE
ABDRH
ACUND
ACYCL
ADNPR
AECWL
DSRVY
ID FETCH-LOGICAL-c377t-93f9dd028789272862a932c1b7149ad7d39562c37ddc03683cbd0a638b7a95fc2
IEDL.DBID 7X8
ISICitedReferencesCount 11
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000437335800026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1437-4331
IngestDate Sun Sep 28 09:50:01 EDT 2025
Thu Apr 03 07:05:19 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords multiples of median
biological variation
blood coagulation tests
haemostasis
pregnancy
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c377t-93f9dd028789272862a932c1b7149ad7d39562c37ddc03683cbd0a638b7a95fc2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 29648994
PQID 2025312529
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2025312529
pubmed_primary_29648994
PublicationCentury 2000
PublicationDate 2018-07-26
PublicationDateYYYYMMDD 2018-07-26
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-07-26
  day: 26
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Clinical chemistry and laboratory medicine
PublicationTitleAlternate Clin Chem Lab Med
PublicationYear 2018
SSID ssj0015547
Score 2.2757833
Snippet During pregnancy, interpretation of results from coagulation parameters can be difficult as the physiological changes that occur may affect the biochemical...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1297
Title Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women
URI https://www.ncbi.nlm.nih.gov/pubmed/29648994
https://www.proquest.com/docview/2025312529
Volume 56
WOSCitedRecordID wos000437335800026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELWAIuDCvpRNRuKIReMsjk8IVVT00KoHlt6qxI4hEk1Cl_wQP8qMk9ITEhKXKHEWRZmXWe15hFzHYBODJFDMdYOQedoXTLYMZ_BPJh5W4rgTWbIJ0e-Hw6Ec1Am3aT2tcqETraLWucIcOQbpABfuc3lXfDJkjcLqak2hsUoaLrgyiGoxXFYRwFRachXPFXZlUN20EUz4rVIfY0AIqGiH89bv7qU1M52d_77gLtmuHUx6XyFij6wk2T7ZbC943fbJRq8upx-Qr9d09p5mbDqPMR1Dq45MKDZaQgxthUZzQ3HxQwlOqaYFIg1OI7vCOM4L8L1naUaRof6GYs8HO_4zYnBBQZYDSGHfMvvQl263S6NM0xKejdkerFzDYX0abi0myRtOz6G2O8Qhee48PLUfWc3awJQrxIxJ10itwW0RoeSCQ8QUgY-onFhAMBZpoV0IyThcq7UC8xm6KtatCNRALCLpG8WPyFqWZ8kJocZIwQMclr6nQxNxIZw49n3lOwnopia5WohiBB8RSx1RluTz6WgpjCY5ruQ5Kqr2HSMsNEOU6Z3-4e4zsgUgCTGZy4Nz0jCgE5ILsq7KWTqdXFq4wbY_6H0DBwvhOQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Within-subject+biological+variation+of+activated+partial+thromboplastin+time%2C+prothrombin+time%2C+fibrinogen%2C+factor+VIII+and+von+Willebrand+factor+in+pregnant+women&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Kristoffersen%2C+Ann+Helen&rft.au=Petersen%2C+Per+Hyltoft&rft.au=Bj%C3%B8rge%2C+Line&rft.au=R%C3%B8raas%2C+Thomas&rft.date=2018-07-26&rft.eissn=1437-4331&rft.volume=56&rft.issue=8&rft.spage=1297&rft_id=info:doi/10.1515%2Fcclm-2017-1220&rft_id=info%3Apmid%2F29648994&rft_id=info%3Apmid%2F29648994&rft.externalDocID=29648994
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1437-4331&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1437-4331&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1437-4331&client=summon